Written answers

Tuesday, 12 July 2022

Department of Health

Medicinal Products

Photo of David CullinaneDavid Cullinane (Waterford, Sinn Fein)
Link to this: Individually | In context | Oireachtas source

159. To ask the Minister for Health the status of the reimbursement pricing negotiations for the cystic fibrosis medication kaftrio for children aged 6 to 11 years; and if he will make a statement on the matter. [37355/22]

Photo of Neale RichmondNeale Richmond (Dublin Rathdown, Fine Gael)
Link to this: Individually | In context | Oireachtas source

933. To ask the Minister for Health when the HSE will make a decision on expanding access to kaftrio for children aged 6 to 11 years with cystic fibrosis; and if he will make a statement on the matter. [37611/22]

Photo of Stephen DonnellyStephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

I propose to take Questions Nos. 159 and 933 together.

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Comments

No comments

Log in or join to post a public comment.